TotalMarketCap

Kala Bio

KALANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.949 M

$0.15 -14.37%

Close of 6 Nov 2026

As of 6 Nov 2026, Kala Bio (KALA) has a market capitalization of $2.95M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$27.0M

Loss-making

Shares outstanding

19,339,786

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #470Ernexa TherapeuticsERNA$3.02M
  2. #471Mustang BioMBIO$2.99M
  3. #472Kala BioKALA$2.95M
  4. #473Clearmind MedicineCMND$2.90M
  5. #474Jupiter NeurosciencesJUNS$2.88M

What if Kala Bio were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,460,041

Per share 9,574,038× higher

Bitcoin $1.53T

$79,000.27

Per share 518,035× higher

Apple $5.02T

$259,350.50

Per share 1,700,659× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for Kala Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.